On June 23,
@mikehildebrand7
from
@Carleton_U
will discuss his team's work developing human spinal cord pain processing models to investigate molecular mechanisms of spinal pain processing in our nextwebinar. Reserve your seat today.
#drugdiscovery
Join us next week for our webinar presented by Dr. Rob Gereau of
@wustl
Pain Center. Learn about his recent
#preclinical
rodent studies to identify key nodes of pain pathway sensitization for new therapeutics.
#painresearch
#drugdiscovery
On June 10, Dr. John Del Rosario, Postdoc Research Associate at Dr. Rob Gereau's Lab at
@WUSTL
Pain Center, will examine endogenous & exogenous mechanisms that modulate activity of Piezo2 & Ca2+- selective TRPV5 channels.
#drugdiscovery
#earlyhumaninsights
New therapeutics are needed to address
#chronicpain
, which affects 20% of adults. Our May webinar, presented by Dr. Ted Price of
@UT_Dallas
, will focus on using human
#DRG
from organ donors to determine underlying pain mechanisms.
#drugdiscovery
On May 28,
@UT_Dallas
prof Dr. Ted Price will present "Human
#DRG
Transcriptomics for Pain Mechanism Discovery & Therapeutic Development." He'll present data using human
#DRG
samples from organ donors to gain insight into
#chronicpain
.
#drugdiscovery
On June 23, Dr. Laura Stone, associate prof at
@mcgillu
will present low back pain findings using human & animal models. She’ll discuss dysregulation of nerve growth factor & immune mediators in human cerebrospinal fluid.
#drugdiscovery
On March 11, Dr. Rob Gereau, Research Vice-Chair at
@WUSTL
Pain Center, will present preclinical studies in rodents identifying key nodes of sensitization in our new webinar, "Translational
#PainResearch
: Targeting Sensitization."
#drugdiscovery
This looped video from our science team shows spontaneous activity (SA) from cultured organotypic human spinal cord slices. It is taken from a 5-min vid and sped to 200 frames/sec. Neurons showing SA were perfused w/ artificial cerebrospinal fluid.
#painresearch
#drugdiscovery
AnaBios is hiring a Research Scientist with expertise in single cell, patch clamp
#electrophysiology
to join our team in San Diego. To learn more or to apply, please visit our NeuroJobs posting.
#EarlyHumanInsights
#drugdiscovery
Join us November 16 for our next webinar about a new human
#spinalcord
platform for preclinical
#drugdiscovery
, presented by CEO Andre Ghetti, Scientist Vivek Jeevakumar &
@NIH
Sr. Researcher Dr. Michael Iadarola.
Dr. John Del Rosario, Postdoc Research Assc at Dr. Gereau's lab at
@WUSTL
Pain Center, will present research about endogenous & exogenous mechanisms modulating Piezo2 and Ca2+- selective TRPV5 channel
activity in our June 10 webinar.
#drugdiscovery
AnaBios is proud to announce it was awarded a SBIR grant by the
#NIH
and
#NCATS
to further advance its unique human
#DRG
platform for pre-clinical drug discovery. Click to read the full announcement.
#drugdiscovery
#EarlyHumanInsights
AnaBios is hiring a Lab Assistant to help support our research activities. Prior experience in lab research and/or electrophysiology is highly desirable. To learn more & apply, visit our
#Careers
page.
#drugdiscovery
#EarlyHumanInsights
#painresearch
#NCATSfunded
awardee Dr. Andre Ghetti, CEO of
@anabioscorp
, shares how
#NCATSsbir
Phase I grant helped advance development of a novel screening platform that could bypass the
#translational
hurdles that impede progress of chronic pain treatment today:
Watch AnaBios' recent webinar featuring Dr. Ted Price, neuroscience professor at
@UT_Dallas
. Dr. Price presented data utilizing human dorsal root ganglia samples from organ donors to gain ew insight into the underlying causes of
#chronicpain
.
.
@biorxivpreprint
recently published new research from AnaBios and
@ucdavis
scientists that shows how designed peptides inhibit Nav1.7 currents in mouse & human sensory neurons. Click the link to read the full paper.
#painresearch
#drugdiscovery
AnaBios is pleased to announce University of Florence professor Romina Nassini, is the winner of our 2nd Annual Translational Research Grant Award. Click to learn more about Dr. Nassini's research.
#drugdiscovery
#earlyhumaninsights
#painresearch
Join us Thursday, September 14, for a webinar presented by Dr. Rajesh Khanna, Director of
@nyuniversity
Pain Research Center. He will delve into the clinical evidence supporting the importance of NaV1.7.
#drugdiscovery
#earlyhumaninsights
Dr. Laura Stone, ass. prof at
@mcgillu
, will explore proof-of-concept studies targeting low back pain mechanisms, and present human & animal study data implicating epigenetic mechanisms in
#chronicpain
in our new webinar.
#painresearch
#drugdiscovery
Dr. William Renthal, Asst Prof of Neurology at Harvard Medical School, will present our next webinar, “Flexible Identity of Peripheral Sensory Neurons After Axonal Injury." Register today.
#painresearch
#EarlyHumanInsights
#drugdiscovery
Dr. Ana Moreno of Navega Therapeutics will present our next webinar on Wednesday, November 9. She'll present a novel
#epigenetic
gene therapy that targets NaV1.7 and has shown to prevent and reverse pain.
#earlyhumaninsights
#drugdiscovery
We are pleased to announce our 2nd Annual
#TranslationalResearch
Grant. The $15,000 award of human tissue samples from AnaBios will help the winning researcher advance his/her project. Click to learn more & apply.
#drugdiscovery
AnaBios offers high-quality human tissue as shown by our RNA integrity number (RIN). All AnaBios human tissue RIN scores were consistently >7 with mean scores >9. Visit our human tissue page to learn more.
#drugdiscovery
#earlyhumaninsights
#neuroscience
On September 30, Ishmail Abdus-Saboor, PhD, Asst Prof at Columbia University, will discuss findings from his team's efforts to uncover a behavioral map of the sensory-versus-motivational pain components in mice.
#drugdiscovery
#translationalresearch
Listen to Chief Corporate Officer Chris Mathes' 6-minute interview with the Legal Drugs Podcast at the 2019 SOT Conference. Dr. Mathes discusses AnaBios' unique translational research platform.
#LegalDrugsPodcast
#DrugDiscovery
#EarlyHumanInsights
AnaBios today announced an investment from Ampersand Capital Partners, a private equity firm specializing in growth equity investments in the life sciences and healthcare sectors. Click to read the full announcement.
#drugdiscovery
#earlyhumaninsights
Dr. Scott MacDonnell, Assoc. Dir. of
#Fibrosis
Research at
@Regeneron
, will present our webinar on April 29 and discuss use of single cell sequencing to identify cell populations from fibrotic tissue & its implications for
#fibrosisresearch
.
#drugdiscovery
AnaBios recently announced a $15,000 grant award for a select academic scientist to utilize our high-quality human tissue to help advance their
#translationalresearch
project. To learn more, visit our website.
#earlyhumaninsights
#drugdiscovery
@NajahAbiGerges
(AnaBios' VP of R&D) in action
@WPC_Congress
in Boston presenting his poster - "Adult human primary cardiomyocyte-based platform for the profiling of positive inotropes with potential to treat heart failure". Message me for a PDF copy.
#DrugDiscovery
#WPC18
We want to thank our staff for their dedication to help continue our critical research. AnaBios is committed to helping the scientific community move important projects forward, including developing a novel therapeutic to end the
#COVID19
pandemic.
#coronavirus
#drugdiscovery
The deadline to submit an abstract for our 2nd Annual Translational Research Grant has been extended to July 15. Click below to learn more info about the grant and submit your abstract.
#drugdiscovery
#earlyhumaninsight
#translationalresearch
AnaBios is hiring a Science Writer to help write & edit scientific marketing materials, including website content, white papers & brochures. To review qualifications and apply, please visit our Careers page.
#drugdiscovery
#earlyhumaninsights
Stream our new
#painresearch
webinar by Dr. Rob Gereau from
@wustl
. He discussed his team's studies in rodents to identify key nodes of pain pathway sensitization. He also discussed human sensory neurons as a
#translationalresearch
tool.
#drugdiscovery
For
#TranslationalTuesday
, we're sharing our latest webinar about selection criteria & variability sources that impact performance of cryopreserved primary human hepatocytes when used in in vitro cell culture.
#drugdiscovery
#earlyhumaninsights
Join us on Monday, December 9, for our latest webinar, "Myocardial Slices: A Novel Discovery Model to Study the Biology of the Human Heart," presented by Dr. Cesare Terracciano, professor of cardiac electrophysiology at Imperial College London.
Join us next Thursday for our webinar, "Evolving Concepts of
#AtrialFibrillation
Mechanisms: Relevance to Therapeutic Innovation," presented by Dr. Stanley Nattel, Professor of Medicine at the University of Montreal.
#earlyhumaninsights
#drugdiscovery
AnaBios announced a research agreement with
@US_FDA
today to study adult human primary cardiomyocytes as a reference for cellular properties & drug-induced effects on cardiac function. Read the full announcement in our News section.
#drugdiscovery
#FDA
Join us January 28 for our webinar, "Chronic Orofacial Pain: From Where We Have Been to Where We Will Go," presented by Dr. Carol Meloto, General Dentist & Asst Dentistry Professor at McGill University.
#painresearch
#EarlyHumanInsights
#drugdiscovery
Dr. William Renthal of Harvard Med School will present our next webinar, “Flexible Identity of Peripheral Sensory
#Neurons
After Axonal Injury." He'll discuss peripheral nerve findings & future applications of single-cell genomics.
#drugdiscovery
AnaBios Business Development Director Richard Kondo will discuss challenges in sourcing human
#biosamples
with other
#pharma
executives in “Cutting Edge Conversations” webinar sponsored by
@scientist_com
on Thursday, October 20.
#drugdiscovery
AnaBios is awarding $15,000 in high-quality human tissue to an academic researcher to advance his/her translational research. The deadline to apply for the research grant is June 30. Click to learn more.
#drugdiscovery
#earlyhumaninsights
The
@US_FDA
has awarded AnaBios a grant to further develop its unique drug discovery platform utilizing
#cardiomyocytes
. Funds will be used to develop a preclinical biomarker to identify pro-arrhythmia risk of potential drugs.
#DrugDiscovery
"Nevertheless, adult human ventricular cardiomyocytes (Nguyen et al.) and trabeculae (Qu et al.) might still be a more reliable model to test the cardiotoxic risk associated with novel drugs, with some advantages over animal and iPSC models."
AnaBios is exhibiting at the 2018
@BIOConvention
in Boston June 4-7. We will provide more information about the selection of a clinical candidate with potential for non-addictive treatment of chronic inflammatory pain. Visit booth 2614 to learn more.
Attending the upcoming BIO 2022 convention in San Diego? Click below to send AnaBios Corporation a meeting request in the BIO partnering system!
#BIO2022
#drugdiscovery
#EarlyHumanInsights
Watch our latest
#webinar
featuring Richard Kondo, Director of Business Development at AnaBios, discussing our high-quality human tissue samples in the latest episode of
@scientist_com
's “Cutting Edge Conversations."
#drugdiscovery
#EarlyHumanInsights
Read about our new human
#cardiomyocyte
webinar & the recent ICH concept paper in the latest edition of Human Insights, our semi-monthly newsletter. Be sure to sign up to receive monthly newsletter updates in your inbox.
#EarlyHumanInsights
#DrugDiscovery
Join us Thurs. for "Discovery & Characterization of ORM-11372: Implications for
#HeartFailure
#DrugDiscovery
," a webinar presented by Jouko Levijoki of
@OrionPharma
. He'll discuss research published in
@BrJPharmacol
and co-authored by AnaBios scientists.
Join us on April 29 as Dr. Scott MacDonnell, Assc. Dir. of
#Cardiovascular
&
#Fibrosis
Research at
@Regeneron
, presents our next webinar focusing on use of single cell sequencing to identify cell populations from fibrotic tissue.
#drugdiscovery
Join our Feb. 4 webinar "Bridging the Translational Divide" presented by Dr. Michael Hildebrand, prof. of neuroscience at Carleton Univ. His team developed a human spinal cord model that parallels rodent pain models.
#translationalresearch
#drugdiscovery